Hartmut Schirok

USPTO Granted Patents = 23 (Patent Applications = 5)

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 14 (Patent Applications = 19)

Average Co-Inventor Count = 8.5

ph-index = 5

Forward Citations = 100(Granted Patents)

Location History:

Dortmund, DE (2006)
Wuppertal, DE (2009 - 2012)
Lagenfeld, DE (2019)
Langenfeld, DE (2012 - 2024)

Company Filing History:

9 out of 721

Bayer Intellectual Property Gmbh

patents

9 out of 378

Bayer Pharma Aktiengesellschaft

patents

3 out of 192

Bayer Schering Pharma Ag

patents

4. 1 out of 383

Lanxess Deutschland Gmbh

Years Active: 2006-2024

Loading Chart...

23 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11884660 - Substituted oxopyridine derivative (2024-01-30),

2. 10183932 - Substituted oxopyridine derivatives and use thereof cardiovascular disorders (2019-01-22),

3. 10077265 - Substituted oxopyridine derivatives (2018-09-18),

4. 10047096 - Substituted pyridobenzodiazepinone-derivatives and use thereof (2018-08-14),

5. 9822102 - Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders (2017-11-21),

6. 9765070 - Substituted oxopyridine derivatives (2017-09-19),

7. 9676766 - Triazolopyridines (2017-06-13),

8. 9670202 - Substituted triazolopyridines (2017-06-06),

9. 9555022 - Substituted triazolopyridines (2017-01-31),

10. 9475815 - Substituted benzothienyl-pyrrolotriazines and uses thereof (2016-10-25),

11. 9434690 - Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders (2016-09-06),

12. 8524722 - Substituted tricyclic compounds and methods of use thereof (2013-09-03),

13. 8487111 - Substituted oxazolidinones and their use (2013-07-16),

14. 8334291 - Aliphatically substituted pyrazolopyridines, and the use thereof (2012-12-18),

15. 8329716 - Hetaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitors (2012-12-11),

Title: The Innovations of Inventor Hartmut Schirok

Introduction:

Hartmut Schirok, a prolific inventor hailing from Langenfeld, Germany, has made significant contributions to the field of pharmaceuticals and cardiovascular health with an impressive portfolio of 23 patents.

Latest Patents:

Among his latest patents is the groundbreaking invention of the Substituted Oxopyridine Derivative. This compound shows promising results in the treatment and prophylaxis of cardiovascular disorders, thrombotic or thromboembolic disorders, edemas, ophthalmic disorders, and the inhibition of plasma kallikrein activity for extracorporeal procedures and analytical assays.

Career Highlights:

Schirok has held key positions at renowned companies such as Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. His innovative spirit and dedication have driven him to create novel solutions for complex medical conditions.

Collaborations:

Throughout his career, Schirok has collaborated with esteemed colleagues like Karl-Heinz Schlemmer and Stefan Heitmeier. Together, they have worked towards pioneering advancements in pharmaceutical research and development.

Conclusion:

Inventor Hartmut Schirok's relentless pursuit of innovation and his groundbreaking patents in the pharmaceutical industry stand as a testament to his expertise and dedication to improving global healthcare. His contributions have the potential to revolutionize the treatment of various diseases, particularly in the realm of cardiovascular health.

This text is generated by artificial intelligence and may not be accurate.